The Pentagon's compromise: drug approvals to remain in FDA's hands
The Senate has unanimously cleared an amendment to the annual defense policy bill that would allow the FDA to retain sole power to approve drugs …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
